Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation

Christine Tompkins, Charles A. Henrikson

Research output: Contribution to journalArticle

Abstract

Choosing the optimal management strategy for antiplatelet and anticoagulation medications at the time of cardiac device implantation can be challenging. Simply withholding or reversing these medications puts patients at risk of subsequent thromboembolic events. Equally, continuing these medications may unnecessarily increase the risk of bleeding complications. This article summarizes recent findings and provides compelling evidence challenging current recommendations outlined by various professional organizations.

Original languageEnglish (US)
Pages (from-to)103-109
Number of pages7
JournalCardiology Journal
Volume18
Issue number1
StatePublished - 2011

Keywords

  • Anticoagulation
  • Complications
  • Implantable cardioverter-defibrillator
  • Pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation'. Together they form a unique fingerprint.

  • Cite this